Results 51 to 60 of about 269,940 (298)

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus

Frontiers in Immunology, 2022
Lupus erythematosus is an autoimmune disease that may manifest in a variety of organs and tissues including the skin, kidney, brain, heart and lung. Many patients present with cutaneous lupus, where disease is often limited to the skin, but are at risk ...
Paul Curtiss, Amanda M. Walker, Benjamin F. Chong   +2 more
doaj   +1 more source

Vitamin D supplementation in systemic lupus erythematosus patients with vitamin D deficiency and insufficiency : the effect on disease activity, fatigue and interferon signature gene expression [PDF]

, 2019
Background: Vitamin D deficiency is highly prevalent among patients with systemic lupus erythematosus (SLE) [1]. Evidence from multiple studies has shown that vitamin D deficiency in SLE is associated with a higher disease activity [2].
Borg, Andrew, Camilleri, Liberato, Magro, Rosalie, Saliba, Christian, Scerri, Christian   +4 more
core   +1 more source

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

Systemic Lupus Erythematosus [PDF]

Pediatric Clinics of North America, 2005
Systemic lupus erythematosus (SLE) in children and adolescents is a multisystem autoimmune disease with a great variability in disease presentation and course. The diagnosis of SLE is based on the clinical and laboratory features consistent with this illness in the absence of other autoimmune disease that could explain the findings.
Susanne M, Benseler, Earl D, Silverman
openaire   +5 more sources

Achados capilaroscópicos no lúpus eritematoso Capillaroscopy findings in lupus erythematosus

Anais Brasileiros de Dermatologia, 2006
FUNDAMENTOS: A capilaroscopia é método não invasivo e reprodutível capaz de analisar diretamente os capilares na região periungueal, auxiliando no diagnóstico diferencial das doenças do tecido conectivo.
Anamaria da Silva Facina, Mario Luiz Cardoso Pucinelli, Mônica Ribeiro Azevedo Vasconcellos, Luci Biaggi Ferraz, Fernando Augusto de Almeida   +4 more
doaj   +1 more source

Системні прояви синдрому токсемії та імунологічна реактивність у хворих на системний червоний вовчак [PDF]

, 2003
In work are submitted researches of a state of an immune responsiveness and mechanisms formation of a set of symptoms of a toxemia at the patients with a systemic lupus erythematosus.
Лозіна, Л.Б., Сміян, С.І.
core  

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

Herpesviruses in Patients With Systemic Lupus Erythematosus (Literature Review and Clinical Cases Description)

Львівський клінічний вісник, 2017
Introduction. Systemic lupus erythematosus is one of the autoimmune diseases prevailing in women of reproductive age and is, quite often, the cause of their disability. In recent years, the attention of researchers has been focused on clarifying the role
Abrahamovych U., Abrahamovych O., Guta S.   +2 more
doaj   +1 more source

Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus. [PDF]

, 2015
Leukopenia is a common manifestation of SLE. Addition of immunosuppressive therapy in a SLE patient who is already leukopenic is a clinical concern. It could worsen leukopenia, increase the risk of infection, or both. The aim of this study was to analyze
Magder, Laurence S., Petri, Michelle, Subedi, Ananta   +2 more
core   +2 more sources